Abstract
Background:
Tandem mass tag (TMT) labeling technology in labeled quantitative proteomics has been widely used in studying differentially expressed proteins (DEPs).
Objectives:
The purpose of the research was to explore DEPs closely associated with optimal initial clinical response.
Methods:
Optimal initial clinical response was defined as a percentage of excess weight loss (%EWL) ≥50%. Using TMT technology and bioinformatics, we screened DEPs to identify those associated with weight-loss outcomes 1 year after surgery. Key DEPs were validated using western blotting and immunohistochemistry in tissue samples from patients with optimal and suboptimal clinical responses.
Results:
We enrolled 26 patients, including 13 with optimal initial clinical response and 13 with suboptimal initial clinical response. Of the 267 DEPs screened, only heat shock protein β2 (HSPβ2) best evaluated the weight loss, with an optimal cutoff of 0.8206 (area under the curve, 1.000; 95% confidence interval: 0.868–1.000; sensitivity, 100.00%; specificity, 100.00%). In an external validation cohort, the HSPβ2 expression was significantly lower in the optimal initial clinical response group than in the suboptimal initial clinical response group.
Conclusions:
HSPβ2 is closely associated with the weight-loss outcome of laparoscopic sleeve gastrectomy.
Get full access to this article
View all access options for this article.
